GSK Investigational Site
Cuernavaca, Morelos 62448
1 studies enrolling now · 15 studies all time
What they study most
Anaemia, Asthma, Diabetes Mellitus, Type 2, Gastrointestinal Neoplasms, Herpes Zoster, Herpes Zoster Vaccine, Influenza, Lupus Nephritis, Pulmonary Disease, Chronic Obstructive, Systemic Lupus Erythematosus
Studies at this site
- A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201) — Recruiting now
- Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND) — Completed
- Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis — Completed
- Study to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and Older — Completed
- Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and Older — Completed
- Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe Asthma — Completed
- A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults — Completed
- Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease — Completed
- A Study In Patients With Type 2 Diabetes Mellitus — Completed
- Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older — Completed
- A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE) — Completed
- Study In Postmenopausal Women With Type 2 Diabetes Looking At Approved Diabetes Drugs And How They Affect Bone Health — Completed
- Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive — Completed
- Study In People With Type 2 Diabetes — Completed
- Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes — Completed